Atsushi Shimoyama

14PUBLICATIONS
38CO-AUTHORS
Innate immunityIndustrial molecular engineering of nucleic acids and proteinsAcceleratorsInfectious agentsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Feb 27, 2026
The Safety of Alcaligenes Lipid A in a Virus-Induced Immune Disease Model Associated with IgA, Th17 Cells, and Microbiota.

Ijaz Ahmad, Seiichi Omura, Sundar Khadka

|Jul 12, 2025
Solid-Phase Oligosaccharide Synthesis with Highly Complexed Peptidoglycan Fragments.

Yuichiro Kadonaga, Ning Wang, Atsushi Shimoyama

|Nov 27, 2024
Development of LAT1-Selective Nuclear Medicine Therapeutics Using Astatine-211.

Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Kentaro Hisada

|Apr 06, 2024
Chemical Synthesis of Acetobacter pasteurianus Lipid A with a Unique Tetrasaccharide Backbone and Evaluation of Its Immunological Functions.

Haruki Yamaura, Atsushi Shimoyama, Koji Hosomi

|Nov 17, 2023
Host extracellular vesicles confer cytosolic access to systemic LPS licensing non-canonical inflammasome sensing and pyroptosis.

Puja Kumari, Swathy O Vasudevan, Ashley J Russo

|May 27, 2023
Evaluation of Astatine-211-Labeled Fibroblast Activation Protein Inhibitor (FAPI): Comparison of Different Linkers with Polyethylene Glycol and Piperazine.

Ayaka Aso, Hinako Nabetani, Yoshifumi Matsuura

Pageof 3

Frequent Collaborators

9 joint publications

Koichi Fukase

4 joint publications

Kazuko Kaneda-Nakashima

3 joint publications

Yoshiyuki Manabe

3 joint publications

Tadashi Watabe